A narrative review on plasminogen activator inhibitor-1 and its (patho) physiological role: to target or not to target?

M Sillen, PJ Declerck - International journal of molecular sciences, 2021 - mdpi.com
Plasminogen activator inhibitor-1 (PAI-1) is the main physiological inhibitor of plasminogen
activators (PAs) and is therefore an important inhibitor of the plasminogen/plasmin system …

Targeting PAI-1 in cardiovascular disease: structural insights into PAI-1 functionality and inhibition

M Sillen, PJ Declerck - Frontiers in Cardiovascular Medicine, 2020 - frontiersin.org
Plasminogen activator inhibitor-1 (PAI-1), a member of the serine protease inhibitor (serpin)
superfamily with antiprotease activity, is the main physiological inhibitor of tissue-type (tPA) …

Multi-omics signatures of the human early life exposome

L Maitre, M Bustamante, C Hernández-Ferrer… - Nature …, 2022 - nature.com
Environmental exposures during early life play a critical role in life-course health, yet the
molecular phenotypes underlying environmental effects on health are poorly understood. In …

A critical review on serine protease: Key immune manipulator and pathology mediator

S Patel - Allergologia et immunopathologia, 2017 - Elsevier
Proteolytic activity is fundamental to survival, so it is not surprising that all living organisms
have proteases, especially seine protease. This enzyme in its numerous isoforms and …

[HTML][HTML] Modulation of BDNF cleavage by plasminogen-activator inhibitor-1 contributes to Alzheimer's neuropathology and cognitive deficits

G Gerenu, E Martisova, H Ferrero, M Carracedo… - … et Biophysica Acta (BBA …, 2017 - Elsevier
Brain-derived neurotrophic factor (BDNF) plays pivotal roles in neuronal function. The
cleaved–mature–form of BDNF (mBDNF), predominantly expressed in adult brains, critically …

High-affinity binding of plasminogen-activator inhibitor 1 complexes to LDL receptor–related protein 1 requires lysines 80, 88, and 207

M Migliorini, SH Li, A Zhou, CD Emal… - Journal of Biological …, 2020 - ASBMB
It is well-established that complexes of plasminogen-activator inhibitor 1 (PAI-1) with its
target enzymes bind tightly to low-density lipoprotein (LDL) receptor-related protein 1 …

Vitronectin inhibits neutrophil apoptosis through activation of integrin-associated signaling pathways

HB Bae, JW Zmijewski, JS Deshane, D Zhi… - American journal of …, 2012 - atsjournals.org
Vitronectin is present in large concentrations in serum and the extracellular matrix. Although
vitronectin is known to modulate neutrophil adhesion and chemotaxis, and to contribute to …

A long-acting PAI-1 inhibitor reduces thrombus formation

S Peng, G Xue, L Gong, C Fang, J Chen… - Thrombosis and …, 2017 - thieme-connect.com
Plasminogen activator inhibitor 1 (PAI-1) is the main inhibitor of tissue-type and urokinase-
type plasminogen activators (t/uPA) and plays an important role in fibrinolysis. Inhibition of …

Crystal structure of plasminogen activator inhibitor-1 in an active conformation with normal thermodynamic stability

JK Jensen, LC Thompson, JC Bucci, P Nissen… - Journal of Biological …, 2011 - ASBMB
The serpin plasminogen activator inhibitor-1 (PAI-1) is a crucial regulator in fibrinolysis and
tissue remodeling. PAI-1 has been associated with several pathological conditions and is a …

Vitronectin inhibits efferocytosis through interactions with apoptotic cells as well as with macrophages

HB Bae, JM Tadie, S Jiang, DW Park… - The Journal of …, 2013 - journals.aai.org
Effective removal of apoptotic cells, particularly apoptotic neutrophils, is essential for the
successful resolution of acute inflammatory conditions. In these experiments, we found that …